PuSH - Publication Server of Helmholtz Zentrum München

Scherer, L.* ; Schönauer, R.* ; Nemitz-Kliemchen, M.* ; Hagemann, T. ; Hantmann, E.* ; de Fallois, J.* ; Petzold, F.* ; Blüher, M. ; Halbritter, J.*

Delta weight loss unlike genetic variation associates with hyperoxaluria after malabsorptive bariatric surgery.

Sci. Rep. 13:9029 (2023)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
The risk of enteric hyperoxaluria is significantly increased after malabsorptive bariatric surgery (MBS). However, its underlying determinants are only poorly characterized. In this case-control study, we aimed at identifying clinical and genetic factors to dissect their individual contributions to the development of post-surgical hyperoxaluria. We determined the prevalence of hyperoxaluria and nephrolithiasis after MBS by 24-h urine samples and clinical questionnaires at our obesity center. Both hyperoxaluric and non-hyperoxaluric patients were screened for sequence variations in known and candidate genes implicated in hyperoxaluria (AGXT, GRHPR, HOGA1, SLC26A1, SLC26A6, SLC26A7) by targeted next generation sequencing (tNGS). The cohort comprised 67 patients, 49 females (73%) and 18 males (27%). While hyperoxaluria was found in 29 patients (43%), only one patient reported postprocedural nephrolithiasis within 41 months of follow-up. Upon tNGS, we did not find a difference regarding the burden of (rare) variants between hyperoxaluric and non-hyperoxaluric patients. However, patients with hyperoxaluria showed significantly greater weight loss accompanied by markers of intestinal malabsorption compared to non-hyperoxaluric controls. While enteric hyperoxaluria is very common after MBS, genetic variation of known hyperoxaluria genes contributes little to its pathogenesis. In contrast, the degree of postsurgical weight loss and levels of malabsorption parameters may allow for predicting the risk of enteric hyperoxaluria and consecutive kidney stone formation.
Impact Factor
Scopus SNIP
Altmetric
4.600
0.000
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Oxalate; Risk
Language english
Publication Year 2023
HGF-reported in Year 2023
ISSN (print) / ISBN 2045-2322
e-ISSN 2045-2322
Quellenangaben Volume: 13, Issue: 1, Pages: , Article Number: 9029 Supplement: ,
Publisher Nature Publishing Group
Publishing Place London
Reviewing status Peer reviewed
Institute(s) Helmholtz Institute for Metabolism, Obesity and Vascular Research (HI-MAG)
POF-Topic(s) 30201 - Metabolic Health
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-506501-001
Grants EKFS
Heisenberg Program
DFG
Fritz Thyssen Foundation (FTS)
Else-Kroner Fresenius Foundation (EKFS)
Deutsche Forschungsgemeinschaft (DFG)
Federal Ministry of Education and Research (BMBF), Germany
Scopus ID 85160878298
PubMed ID 37270618
Erfassungsdatum 2023-10-06